...
首页> 外文期刊>Journal of Virology >Tumor induction by simian virus 40 in mice is controlled by long-term persistence of the viral genome and the immune response of the host.
【24h】

Tumor induction by simian virus 40 in mice is controlled by long-term persistence of the viral genome and the immune response of the host.

机译:小鼠中猿猴病毒40的肿瘤诱导由病毒基因组的长期持续性和宿主的免疫应答控制。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Simian virus 40 (SV40), which transforms mouse cells in vitro, has not been previously observed to cause tumors when injected in immunocompetent mice. We have investigated both the fate of the injected virion in mice and several immunological parameters as potential factors controlling tumorigenicity. We find that although SV40 does not replicate in mouse cells, the viral DNA can persist for many months postinjection; the majority of the viral DNA is found in the cytoplasm, but a small amount of the viral DNA is integrated at multiple sites in the host nuclear DNA. The persistence of the viral genome is independent of the ability of the mouse to mount an SV40 TSTA specific cytotoxic T-cell response and may be attributed to the cytoplasmic location of the majority of the viral genome. However, in long-term studies of SV40-injected mice, genetically identical except for the major histocompatibility complex, we find that tumors were induced in some mice of the H-2d (low cytotoxic T-lymphocyte responder to SV40 TSTA) but not of the H-2k (high responder to SV40 TSTA) haplotype. Thus, a combination of inefficient disposal of the injected virion and inefficient immunological surveillance and elimination of cells containing nuclear SV40 DNA can eventually result in SV40-induced tumors at multiple sites in mice.
机译:在体外转化小鼠细胞的Simian病毒40(SV40)尚未观察到在免疫活性小鼠中注射时引起肿瘤。我们已经研究了小鼠中注射病毒中的命运和若干免疫参数作为控制致瘤性的潜在因素。我们发现,尽管SV40未在小鼠细胞中复制,但病毒DNA可以持续数月推出;大多数病毒DNA在细胞质中发现,但少量的病毒DNA集成在核核DNA中的多个位点。病毒基因组的持续性与小鼠安装SV40TSTA特异性细胞毒性T细胞响应的能力无关,并且可以归因于大多数病毒基因组的细胞质位置。然而,在SV40注射小鼠的长期研究中,除了主要的组织相容性综合性外,遗传相同,我们发现在H-2D的一些小鼠中诱导肿瘤(低细胞毒性T淋巴细胞响应者至SV40 TSTA)但不是H-2K(高响应到SV40TSTA)单倍型。因此,含有核SV40 DNA的注射病毒尼氏患者和低效免疫监测和消除细胞的低效处理的组合最终可能导致小鼠多个位点的SV40诱导的肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号